With Latest Round Of Cuts, China Continues March To Narrow Gap Between Big Pharma And Local Generics
• By PharmAsia News
SHANGHAI - As expected, China's powerful National Development and Reform Commission announced Aug. 5 a new round of price cuts, this time targeting hormone and endocrinology drugs and central nervous system drugs, with an average cut of roughly 14%, according to analysts
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
